Clinical Trials Research Services, LLC

Pittsburgh, Pennsylvania 15206

0 studies enrolling now · 23 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Arthritis, Binge Eating Disorder, Chronic Constipation, Chronic Idiopathic Constipation, Heart Septal Defects, Atrial, Hot Flashes, Irritable Bowel Syndrome, Irritable Bowel Syndrome With Constipation, Major Depressive Disorder, Menopause

Studies at this site

• Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women — Completed
• Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream) — Completed
• Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip — Stopped early
• Open Label Extension in Adults With Binge Eating Disorder (BED) — Completed
• SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder — Completed
• A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms — Completed
• An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation — Completed
• ESCAPE Migraine Trial — Stopped early
• Safety and Tolerability Extension Trial for Patients With Chronic Idiopathic Constipation — Completed
• Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients — Stopped early
• 26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation — Stopped early
• 24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms — Completed
• Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS) — Completed
• A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation — Completed
• A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease — Completed
• Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation — Completed
• A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine — Completed
• A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease — Stopped early
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) — Completed
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) — Completed
• Study Comparing Adjunctive Risperidone Versus Placebo in Major Depressive Disorder That Is Not Responding to Standard Therapy — Completed
• Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD) — Completed
• A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females — Status unconfirmed